SCHEMBL9952519

SCHEMBL9952519

NC(=O)NC(CO)C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 3/20 0.46
CAD P27708 1/20 0.38
CA2 P00918 5/20 0.36
CA9 Q16790 3/20 0.36
CA1 P00915 3/20 0.36
CA12 O43570 2/20 0.36
SCN9A Q15858 3/20 0.32
TSHR P16473 2/20 0.32
NFKB1 P19838 2/20 0.32
LMNA P02545 2/20 0.32
CYP1A2 P05177 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
THPO P40225 1/20 0.32
CYP3A4 P08684 1/20 0.32
CA5A P35218 1/20 0.32
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
ECE1 P42892 1/20 0.31
IL1RN P18510 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17987676 0.85 TGFBR1 (0.43) TGFBR1CADCA2CA9CA1
SCHEMBL2793957 0.82 TGFBR1 (0.68) TGFBR1CADCA2CA1NFKB1
SCHEMBL14050301 0.82 TGFBR1 (0.50) TGFBR1CA2CA9CA1CA12
SCHEMBL2793959 0.82 TGFBR1 (0.68) TGFBR1CADCA2CA1NFKB1
SCHEMBL2307007 0.82 TGFBR1 (0.68) TGFBR1CADCA2CA1NFKB1
SCHEMBL9952740 0.80 TGFBR1 (0.43) TGFBR1CA2CA9CA1CA12
SCHEMBL468816 0.80 KDM4E (0.45) TGFBR1CA2CA9CA1CA12
SCHEMBL1576871 0.80 KDM4E (0.45) TGFBR1CA2CA9CA1CA12
SCHEMBL468815 0.80 KDM4E (0.45) TGFBR1CA2CA9CA1CA12
SCHEMBL18569190 0.78 TGFBR1 (0.42) TGFBR1CA2CA9CA1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655330-A1 SUBSTITUTED PYRIDINES AS SODIUM CHANNEL BLOCKERS Purdue Pharma LP (US) 2013-10-30 EP disclosed
WO-2012085650-A1 SUBSTITUTED PYRIDINES AS SODIUM CHANNEL BLOCKERS PURDUE PHARMA L.P. (US) 2012-06-28 WO disclosed